Chronic Active Hepatitis with High Level of Anti-ds-DNA Detected by a Solid Phase Radioimmunoassay

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 1982 Sep 1

PMID 6985373

Citations 3

Authors

A Peretz

G Nuttin

J P Famaey

Affiliations

Soon will be listed here.

Abstract

A case of chronic active hepatitis with arthralgia in a 72-year-old woman was diagnosed on the basis of biological and histological findings. High levels of anti-ds-DNA usually considered specific for systemic lupus erythematosus were detected by a very sensitive solid-phase radioimmunoassay.

Citing Articles

A graft-versus-host-like reaction as the cause of anti-ds-DNA antibody in chronic active hepatitis.

Cheung C Clin Rheumatol. 1983; 2(3):303.

PMID: 6331970 DOI: 10.1007/BF02041407.

Measurement of serum DNA binding in chronic active hepatitis and systemic lupus erythematosus using the Farr assay.

Pollard K, Steele R, Hogg S, Webb J Rheumatol Int. 1986; 6(3):139-44.

PMID: 3529336 DOI: 10.1007/BF00270351.

Liver abnormalities and liver membrane autoantibodies in systemic lupus erythematosus.

Kushimoto K, Nagasawa K, Ueda A, Mayumi T, Ishii Y, Yamauchi Y Ann Rheum Dis. 1989; 48(11):946-52.

PMID: 2596885 PMC: 1003919. DOI: 10.1136/ard.48.11.946.

References

Summerskill W, Korman M, Ammon H, BAGGENSTOSS A . Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut. 1975; 16(11):876-83. PMC: 1413126. DOI: 10.1136/gut.16.11.876. View

Aotsuka S, Okawa M, Ikebe K, Yokohari R . Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes. J Immunol Methods. 1979; 28(1-2):149-62. DOI: 10.1016/0022-1759(79)90337-5. View

Jain S, Markham R, Thomas H, Sherlock S . Double-stranded DNA-binding capacity of serum in acute and chronic liver disease. Clin Exp Immunol. 1976; 26(1):35-41. PMC: 1540802. View

Reynolds T . Chronic hepatitis: current dilemmas. Am J Med. 1980; 69(4):485-7. DOI: 10.1016/0002-9343(80)90458-1. View

Canoso J, Cohen A . A review of the use, evaluations, and criticisms of the preliminary criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1979; 22(8):917-21. DOI: 10.1002/art.1780220817. View

Grossman J, Callerame M, CONDEMI J . Skin immunofluorescence studies on lupus erythematosus and other antinuclear-antibody-positive diseases. Ann Intern Med. 1974; 80(4):496-500. DOI: 10.7326/0003-4819-80-4-496. View

Kingham J, Rassam S, Ganguly N, McGuire M, Nasrat B, Holgate S . DNA-binding antibodies and hepatitis B markers in acute and chronic liver disease. Clin Exp Immunol. 1978; 33(2):204-10. PMC: 1537574. View

Arden L, Lakmaker F, FELTKAMP T . Immunology of DNA. II. The effect of size and structure of the antigen on the Farr assay. J Immunol Methods. 1976; 10(1):39-48. DOI: 10.1016/0022-1759(76)90005-3. View

Doniach D, Roitt I, Walker J, Sherlock S . Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966; 1(3):237-62. PMC: 1579190. View

10.

Venables P, Erhardt C, Maini R . Antibodies to extractable nuclear antigens in rheumatoid arthritis: relationship to vasculitis and circulating immune complexes. Clin Exp Immunol. 1980; 39(1):146-53. PMC: 1537954. View

11.

Sherlock S . Chronic hepatitis. Gut. 1974; 15(7):581-97. PMC: 1412970. DOI: 10.1136/gut.15.7.581. View

12.

Davis P, Read A . Antibodies to double-stranded (native) DNA in active chronic hepatitis. Gut. 1975; 16(6):413-5. PMC: 1411032. DOI: 10.1136/gut.16.6.413. View

13.

Fish F, ZIFF M . A sensitive solid phase microradioimmunoassay for anti-double stranded DNA antibodies. Arthritis Rheum. 1981; 24(3):534-43. DOI: 10.1002/art.1780240314. View

14.

Bresnihan B, Jenkins W, Chadwick V, Hughes G . Chronic active hepatitis in a patient presenting with clinical and serological evidence of SLE. J Rheumatol. 1979; 6(1):38-42. View

15.

Davis P, PERCY J, Russell A . Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann Rheum Dis. 1977; 36(2):157-9. PMC: 1006651. DOI: 10.1136/ard.36.2.157. View

16.

Reichlin M . Current perspectives on serological reactions in SLE patients. Clin Exp Immunol. 1981; 44(1):1-10. PMC: 1537211. View

17.

BURNHAM T, FINE G . The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin. Arch Dermatol. 1971; 103(1):24-32. View

18.

Seaman W, Ishak K, Plotz P . Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med. 1974; 80(1):1-8. DOI: 10.7326/0003-4819-80-1-1. View

19.

Gershwin M, Glinski W, Bender A, Ringel S, Steinberg A, Engel W . Antibodies to nucleic acids in myasthenia gravis. Int Arch Allergy Appl Immunol. 1976; 51(2):245-52. DOI: 10.1159/000231597. View

20.

Locker J, Medof M, Bennett R, Sukhupunyaraksa S . Characterization of DNA used to assay sera for anti-DNA antibodies; determination of the specificities of anti-DNA antibodies in SLE and non-SLE rheumatic disease states. J Immunol. 1977; 118(2):694-701. View